LESLIE KRUG: Open Payments
NPI 1265493340 · DUNCANSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,570 in 462 payments from 24 companies in 2025. Trend: 2023 $4,125 · 2024 $5,434 · 2025 $6,570
Food & beverage: $6,470Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 197 | $2,177 |
| Janssen Biotech, Inc. | 42 | $775 |
| Amgen Inc. | 31 | $742 |
| UCB, Inc. | 51 | $622 |
| AstraZeneca Pharmaceuticals LP | 17 | $478 |
| PFIZER INC. | 47 | $358 |
| Novartis Pharmaceuticals Corporation | 19 | $228 |
| GlaxoSmithKline, LLC. | 14 | $220 |
| E.R. Squibb & Sons, L.L.C. | 10 | $194 |
| Lilly USA, LLC | 5 | $106 |
Products named: RINVOQ, TREMFYA, Bimzelx, SKYRIZI, SAPHNELO, XELJANZ, COSENTYX, BENLYSTA.
Industry payments across PA — which companies pay providers there.
